This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Beckman Coulter, Inc., Coulter International Corp.. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Luisa Oramas: Innovator in Hematology Reagents
Introduction
Luisa Oramas is a notable inventor based in Weston, FL (US). She has made significant contributions to the field of hematology through her innovative patents. With a total of 2 patents, her work focuses on improving blood analysis methods.
Latest Patents
One of her latest patents is a cyanide-free lytic reagent composition and method of use for hemoglobin and white blood cell measurement. This invention provides a safer alternative for measuring total hemoglobin concentration and white blood cells in blood samples. The lytic reagent composition includes a quaternary ammonium surfactant that lyses red blood cells, releasing hemoglobin, and a ligand that forms a stable chromogen with the hemoglobin. The composition is designed to operate within a pH range of 3 to 10. Additionally, she has developed a low formaldehyde producing blood diluent that contains ethylenediamine tetraacetic acid and other effective components, ensuring minimal formaldehyde production during blood analysis.
Career Highlights
Luisa has worked with prominent companies in the field, including Beckman Coulter, Inc. and Coulter International Corp. Her experience in these organizations has contributed to her expertise in developing innovative solutions for blood analysis.
Collaborations
Some of her notable coworkers include Barbara Murza and Russell F. Lang. Their collaboration has likely fostered a creative environment for developing groundbreaking inventions.
Conclusion
Luisa Oramas stands out as an influential inventor in the field of hematology, with her innovative patents paving the way for safer and more effective blood analysis methods. Her contributions continue to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
